J7528 HCPCS Level II code: Mycophenolate mofetil, for suspension, oral, 100 mg
CMS terminated J7528: its last date of service was Sep 30, 2026. It stays here for looking up older claims; newer services need a current code.
Official description
J7528Mycophenolate mofetil, for suspension, oral, 100 mg
Short description: Mycophen mofetil for susp
HCPCS · United States
Medicare details
The indicators CMS publishes with J7528 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Immunosuppressive drugs
- BETOS category
- Other drugs
- Added
- Jan 1, 2026
- Terminated after
- Sep 30, 2026
Where J7528 sits
- 1J codesDrugs administered other than orally
- 2Terminated J7528Mycophenolate mofetil, for suspension, oral, 100 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J7528 still valid?
No. CMS terminated J7528; its last date of service was Sep 30, 2026. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J7528?
CMS lists J7528’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7528
All J codesJ7520Sirolimus, oral, 1 mgJ7521Tacrolimus, granules, oral suspension, 0.1 mgJ7524Mycophenolate mofetil, oral, 5 mgJ7525Tacrolimus, parenteral, 5 mgJ7526Injection, mycophenolate mofetil, 5 mgJ7527Everolimus, oral, 0.25 mgJ7529Mycophenolate mofetil, for suspension, oral, 5 mgJ7530Mycophenolate mofetil (myhibbin), oral suspension, 5 mgJ7531Prednisolone sodium phosphate, orally disintegrating tablet, 1 mgJ7599Immunosuppressive drug, not otherwise classifiedJ7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mgJ7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram